We wrap up 2021 and our first year of the Baby Giants Investing podcast with our most important reflections and lessons. 

We sink our teeth into Marley Spoon's meal-kit business, and have some last minute book recommendations for everyone's Christmas list.

Alcidion makes a big acquisition, Bapcor's CEO drama gets a public airing, volatility returns, and we chat what makes Aussie small caps such a wild market.

A new Covid variant called Omicron has the world worried. How serious is it, and how should we think about it as investors? Meanwhile Nanosonics has been a strong performer over recent years - but what's the investment case today? Andrew, Kev, Matt, and Claude dig in.

Andrew, Kevin, Claude and Matt chat through Bapcor's CEO departure, the unit economics of Beforepay, the long history of Catapult, and a Pushpay listener question.

Pushpay (ASX:PPH) and Cluey (ASX:CLU) are two businesses that have caught a strong covid tailwind, but how will they fair now that covid is (finally) coming to an end? Listen in as Andrew, Claude, Matt, and Kev dig in. 

Kevin, Claude, Andrew, and Matt have questions. Is Infomedia (ASX:IFM) a cheap recurring revenue enterprise software business? Or is the rise of electric vehicles going to cause it to break down? Has MSL Solutions (ASX:MSL) turned the corner to profitable growth? When should you give a Directors a second chance? 

Loved by bulls, doubted by bears, battleground stock Redbubble (ASX:RBL) is now the second most shorted stock on the ASX, Matt, Kevin & Andrew talk through the key arguments on both sides. Then Andrew runs us through AVA Risk Group (ASX:AVA) an under the radar small cap that's making intruders tread carefully.